Lysophosphatidic acid metabolism and signaling in heart disease
Canadian Journal of Physiology and Pharmacology · 01.12.2024 · 102 (12) · 685-696
DOI: 10.1139/cjpp-2024-0077 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Physiology and Pharmacology, erschienen am 01.12.2024. Verfasst von Anu Jose und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Dalhousie University, Dalhousie Medicine New Brunswick, Saint John, NB, Canada. Hauptthemen laut MEDLINE: Lysophospholipids, Signal Transduction, Heart Diseases, Receptors, Lysophosphatidic Acid. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Circulatory and Respiratory Health, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Lysophosphatidic acid (LPA) is a bioactive lipid that is mainly produced by the secreted lysophospholipase D, autotaxin (ATX), and signals through at least six G protein-coupled receptors (LPA1–6). Extracellular LPA is degraded through lipid phosphate phosphatases (LPP1, LPP2, and LPP3) at the plasmamembrane, terminating LPA receptor signaling. The ATX–LPA–LPP3 pathway is critically involved in a wide range of physiological processes, including cell survival, migration, proliferation, angiogenesis, and organismal development. Similarly, dysregulation of this pathway has been linked to many pathological processes, including cardiovascular disease. This review summarizes and interprets current literature examining the regulation and role of the ATX–LPA–LPP3 axis in heart disease. Specifically, the contribution of altered LPA metabolism via ATX and LPP3 and resulting changes to LPA receptor signaling in obesity cardiomyopathy, cardiac mitochondrial dysfunction, myocardial infarction/ischemia-reperfusion injury, hypertrophic cardiomyopathy, and aortic valve stenosis is discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Dalhousie University, Dalhousie Medicine New Brunswick, Saint John, NB, Canada.
ORCID-Profile: Petra C Kienesberger
Förderung
- Institute of Circulatory and Respiratory Health
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Jose, A., Fernando, J. J., & Kienesberger, P. C. (2024). Lysophosphatidic acid metabolism and signaling in heart disease. Canadian Journal of Physiology and Pharmacology, 102(12), 685-696. https://doi.org/10.1139/cjpp-2024-0077
Vancouver
Jose A, Fernando JJ, Kienesberger PC. Lysophosphatidic acid metabolism and signaling in heart disease. Canadian Journal of Physiology and Pharmacology. 2024;102(12):685-696. doi:10.1139/cjpp-2024-0077
BibTeX
@article{Jose2024,
author = {Jose, Anu and Fernando, Jeffy J and Kienesberger, Petra C},
title = {Lysophosphatidic acid metabolism and signaling in heart disease},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2024},
volume = {102},
number = {12},
pages = {685--696},
doi = {10.1139/cjpp-2024-0077}
}
EUVIMED